Latest Biotech News

Innovations in microscopy and electron tomography promise to accelerate research. A new rapid, automated multiscale electron tomography technique optimizes visualization of sensitive materials...

Collaborative research between The University of Texas at Arlington and City of Hope focuses on long-term health challenges faced by childhood cancer survivors, emphasizing the role wearable...

Researchers have developed an innovative fruit dehydration method that operates at room temperature using controlled atmospheric pressure and food-safe calcium chloride, eliminating the...

Novartis has announced successful results from two Phase 3 trials of its antibody drug ianalumab in Sjögren’s syndrome, marking the first global studies demonstrating statistically significant...

IO Biotech’s cancer vaccine Cylembio, tested in combination with Merck’s Keytruda for unresectable or metastatic melanoma, narrowly failed to meet its primary progression-free survival endpoint in...

Thermo Fisher Scientific has obtained FDA approval for its Oncomine Dx Target Test as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS®, a tyrosine kinase inhibitor targeting...

Exact Sciences has acquired U.S. rights to Freenome’s colorectal cancer blood test for $75 million upfront, positioning itself against market rival Guardant Health in the liquid biopsy segment....

Investment bank Canaccord Genuity downgraded Quanterix shares from Buy to Hold, lowering the price target to $5 following disappointing Q2 2025 revenues and uncertainties in the integration of...

Sartorius Stedim Biotech has partnered with Nanotein Technologies, acquiring a minority stake to support commercialization and joint development of immune cell activation solutions based on...

Researchers have demonstrated that fecal microbiome transplantation from fibromyalgia patients induces chronic pain symptoms in germ-free mice, establishing a causal role of gut microbes in...

Advances in machine learning have led to novel computational models that significantly improve prediction, diagnosis, and management of heart diseases such as stroke and myocardial infarction....

A novel gastrointestinal neuroprosthetic device has been developed to interface with the enteric nervous system, enabling precise neuromodulation of gut motility and metabolism. This bioelectronic...

Vinay Prasad has been reinstated as the director of the Center for Biologics Evaluation and Research (CBER) at the FDA, just weeks after his unexpected departure amid political controversy. The...

Vinay Prasad has been reinstated as the director of the FDA's Center for Biologics Evaluation and Research (CBER) just weeks after his abrupt ouster, following internal controversy and political...

Novartis announced positive results from two pivotal Phase 3 clinical trials (Neptunus 1 and 2) demonstrating that its antibody drug ianalumab significantly reduced disease activity in patients...

Canaccord Genuity downgraded Quanterix’s stock from Buy to Hold, cutting its price target from $12 to $5 after the company's Q2 2025 revenues fell 29% year-over-year due to weak pharmaceutical and...

Exact Sciences is acquiring U.S. rights to Freenome’s colorectal cancer liquid biopsy test with a $75 million upfront payment, positioning to challenge Guardant Health in the expanding early...

Research teams have unveiled AI-driven models that significantly improve hospital admission predictions from emergency departments, aiming to reduce overcrowding and enhance patient care...

Recent studies have elucidated how gut and microbial flora influence neurodegenerative and chronic pain conditions. Research implicates specific Desulfovibrio bacterial strains in...

Greater Boston’s life sciences real estate sector confronts unprecedented vacancy rates, reaching 29.7% including subleases, fueled by speculative construction exceeding tenant demand amid a...